Content uploaded by Pietro Ivo D'Urso
Author content
All content in this area was uploaded by Pietro Ivo D'Urso on Aug 21, 2015
Content may be subject to copyright.
02
Try before you buy
To request trial access,
contact us at:
trials@future-science-group.com
or on +44 (0)20 8371 6090
INSTITUTIONAL TRIALS
If you would like to trial our content, just get in touch. Trials can
be on single publications or entire collections, the choice is yours.
We will work with you to decide on the best time and duration
for your institution.
During the trial period, you have:
•Full-text access to the titles you select
•Detailed usage statistics from our Atypon-backed platform
•Support from our in-house technical team
•Control over the duration, visibility and promotion of the trial
Fair usage limits apply. For more details speak to a member of
our team.
03
Vision in
Scientific and
Medical Publishing
WELCOME
Last year was defined by our mission to keep pace with scientific endeavor. Recognizing gaps in specific areas of
translational medicine, we launched Hepatic Oncology, Melanoma Management and the International Journal
of Endocrine Oncology. We also significantly expanded our drug discovery, oncology, neurology and infectious
diseases eBook portfolios in response to reader demand.
In 2014, our online reach also grew significantly. Visits to our content websites grew by 21% year-on-year, driven
in part by the addition of CNS Oncology, Neurodegenerative Disease Management and Pain Management to
MEDLINE. The Bioanalysis LinkedIn community now numbers over 2,200 members, while its sister website,
Bioanalysis Zone, includes over 7,000 registrants. In addition, all of our journals are now integrated with social
media, ensuring that researchers can stay up-to-date with our research as it is published.
Finally, the Journal of Comparative Effectiveness Research welcomed its first Impact Factor, only two years after
launch. It continues to be the only comparative effectiveness journal indexed on MEDLINE. Five other journals
also saw a significant and organic uplift in their Impact Factor – proof that our content is read and valued by a
wide variety of customers all over the world.
While we will continue to intelligently expand our portfolio in the year ahead, our commitment to quality and
value for customers will remain constant. Further growth of our eCommunities will remain top priority, as will
developing new models of access.
I sincerely look forward to working with you in the year ahead; as does my team. It will be a dynamic time for
the company as we seek to further enhance our products for researchers and clients alike.
Sincerely,
Phil Garner
Managing Director, Future Science Group
Advancing clinical practice and drug
research by enhancing communication
ABOUT US
Founded in 2001, Future Science Group is a progressive publisher focused
on breakthrough medical, biotechnological and scientific research.
Future Science Group’s portfolio consists of two imprints, Future
Science and Future Medicine. Both publish eBooks and journals. In
addition to this core publishing business, Future Science Group develops
specialist eCommunities. Key titles and sites include Bioanalysis Zone,
Pharmacogenomics and the award-winning Regenerative Medicine.
The aim of Future Science Group is to serve the advancement of clinical
practice and drug research by enhancing the efficiency of communication
among clinicians, researchers and decision-makers, and by providing
innovative solutions to their information needs. This is achieved through
a customer-centric approach, use of new technologies, products that
deliver value-for-money and uncompromisingly high standards.
Learn more about Future Science Group at
www.future-science-group.com
51 employees
34 journals,
18 indexed on MEDLINE
Over 160 eBooks
eCommunities for niche
medical and scientific
specialties
04
Publisher of
journals, eBooks
and eCommunities
CONTENTS
Trials ......................................... 2
Welcome ................................. 3
About us .................................. 4
Readership ............................... 6
Editorial Values ......................... 7
Information for Librarians ........ 8
Contact us ............................. 24
PUBLICATIONS
Overview .................................. 9
Future Medicine Journals ....... 10
Future Science Journals ......... 16
eBooks ................................... 18
eCommunities ....................... 20
SERVICES
Publishing Solutions ............... 22
Marketing and Communication
Support ................................. 23
05
A global network of researchers,
practitioners and policy-makers
READERSHIP
Our readership spans specialists
in bioscience and medical
practice across the globe.
Our key reader groups are:
•Clinical, basic and
translational researchers
in academia, industry,
hospitals and government
research organizations
•Policy and decision-makers
in government
and industry
•Those with an interest in
pharmaceutical patents/IP
•Clinicians in primary and
secondary care, including:
cardiologists, hematologists,
immunologists, infectious
disease specialists,
neurologists, OB/GYN
practitioners, oncologists
and rheumatologists
FUTURE MEDICINE
www.futuremedicine.com
28 journals; 137 eBooks
Last 12 months*:
•4.3 million page views
•1.2 million users
•2.1 million abstract views
•627,000 full-text downloads
•Top 5 countries
FUTURE SCIENCE
www.future-science.com
6 journals; 27 eBooks
Last 12 months*:
•1.3 million page views
•340,000 users
•520,000 abstract views
•230,000 full-text downloads
•Top 5 countries
06
USA (28%) USA (28%)
UK (9%) UK (9%)
China (7%) India (9%)
India (6%) China (7%)
Canada (3%) Germany (4%)
* as of August 5, 2014
Upholding the highest standards of editorial
expertise and integrity
EDITORIAL VALUES
Future Science Group upholds the highest standards of editorial
integrity, including disclosure and independent peer-review. Future
Science Group adheres to the guidelines set by COPE and ICMJE,
endorses CONSORT and follows the recommendations set by GPP2.
A unique feature of our editorial process is full in-house management;
all Future Science Group managing editors are based in our London
headquarters. Our managing editors all hold a relevant bioscience
degree, ensuring an informed evaluation of all of our content.
All journals are also supported through guidance from their editorial
boards.
Editorial board members
represent the world’s most
prestigious organizations,
including:
•National Institutes of Health,
USA
•Cedars-Sinai Medical Center,
USA
•Harvard University, USA
•Cancer Research UK, UK
•University College London,
UK
•Cambridge University, UK
•Tel-Aviv University, Israel
•Karolinska Institute, Sweden
•Leiden University, The
Netherlands
•National Cancer Center,
Japan
•Seoul National University,
Korea
•Peking University, China
07
Abstracted and
indexed in all the
main databases
SERVICES
•Flexible purchasing
•Accessible for all
institution types
•COUNTER-compliant
usage reports
•ATHENS & Shibboleth
authentication compliant
•Reliable publishing platform
•Dynamic customer services
•Promotion tools
upon request
PRICING
Pricing is calculated using
institution type:
•Academic/Hospitals –
prices are independent
of institutional size
•Corporate, Government –
bands based on FTE and the
number of research sites
INFORMATION FOR LIBRARIANS
INSTITUTIONAL AND ACADEMIC SUBSCRIPTIONS
Future Science Group operates a pricing model in which the type and
size of the subscribing institution determines the subscription rate.
CONSORTIA
Future Science Group works with consortia of various types and sizes
and welcomes discussion with all consortium managers. COUNTER-
compliant usage statistics are provided for each institution. The benefits
for the consortium include discounts on list price. Members have the
flexibility to select the publications they want to include, or Future
Science Group will work with the consortium to create customized
packages.
INDEXING
Future Science Group titles are abstracted and indexed in all the main
databases including MEDLINE/Index Medicus, EMBASE/Excerpta Medica
and Thomson Science Citation Index.
08
Cutting-edge coverage of postgenomic
scientific and medical information
TIMELY REVIEWS & HIGH-
QUALITY ORIGINAL RESEARCH
Our titles blend commissioned
and unsolicited content to
ensure that your team is kept
comprehensively updated
on the latest advances and
techniques in bioscience and
clinical practice, whatever your
discipline.
HIGHLY STRUCTURED FORMAT
Quality design enhances
comprehension. To speed up
learning and save researchers
time, articles and chapters are
augmented by an easy-to-read,
specially structured format.
HIGH-SPEED AND HIGH-
FREQUENCY PUBLICATIONS
To keep pace with scientific
endeavor, peer-reviewed content
is available in as little as six
weeks from submission. Issues
are published up to 24 times
a year, ensuring access to the
latest findings.
HIGH VISIBILITY
To ensure 24/7 access, all titles
are hosted on Atypon platforms
– a market leader in content
management. Our journals are
also indexed on many of the
leading abstracting services
including MEDLINE, Thomson
Science Citation Index, EMBASE
and Chemical Abstracts.
09
PUBLICATION OVERVIEW
Future Medicine
Journals
10
Information needs in clinical and
translational medicine and the biosciences
FUTURE SERIES
The journals in the Future
Series adopt a forward-looking
stance toward the scientific
and clinical issues, together
with the economic and policy
issues that confront us in a
new era of care.
Delivered in a concise format,
Future Series journals are
shaped to meet the needs of
time-constrained practitioners
and policy-makers.
Future Oncology
MEDLINE-indexed
Impact Factor: 2.611
24 issues per year
22,555 abstract views/month
Provides updates on oncology
research, ranging from the
bench to the bedside
Associated eCommunity:
Oncology Central
Future Microbiology
MEDLINE-indexed
Impact Factor: 3.819
12 issues per year
17,450 abstract views/month
Covers microbiological areas
including all pathogen types
and microbe–host interactions
Future Cardiology
MEDLINE-indexed
6 issues per year
6650 abstract views/month
Covers the advances in basic,
translational and clinical
cardiology research
Future Neurology
CME articles
6 issues per year
3280 abstract views/month
Advances in basic, translational
and clinical neurology research
Future Virology
Impact Factor: 1.0
12 issues per year
4075 abstract views/month
Latest updates in virology,
infectious disease and
immunology analysis
11
Three high-impact journals covering the
fastest growing areas of bioscience
The three journals in the Future
Medicine Essentials series
represent three of the fastest
growing areas of bioscience.
Amongst the first journals in
their respective fields, these
journals feature high Impact
Factors, MEDLINE-indexing and
significant readership.
Regenerative Medicine
MEDLINE-indexed
Impact Factor: 3.5
8 issues per year
11,015 abstract views/month
Up-to-date research for
the translation of stem cell
therapies from the laboratory
to patients
Associated eCommunity:
RegMedNet
Nanomedicine
MEDLINE-indexed
Impact Factor: 5.824
24 issues per year
26,364 abstract views/month
Advances in medical
nanoscale-structured material
and devices
Pharmacogenomics
MEDLINE-indexed
Impact Factor: 3.425
18 issues per year
20,930 abstract views/month
Research and comment on
the role of genetics in
drug response
12
FUTURE MEDICINE ESSENTIALS
Three new journals
for tomorrow’s
medicine
NEWLY LAUNCHED
Medicine may be broad,
but treatment is specific.
These three journals focus
on the most dynamic topics
in tomorrow’s medicine, as
selected by the experts on our
editorial boards.
Hepatic Oncology
Original research studies and
reviews addressing preventive,
diagnostic and therapeutic
approaches to all types of
cancer of the liver, in both the
adult and pediatric populations
International Journal of
Endocrine Oncology
Focuses specifically on cancers
of the endocrine system,
with articles targeted to the
time-constrained clinician
Melanoma Management
Clinical aspects of treating a
patient with melanoma
aimed at the practising
clinician, as well as scientists
conducting translational and
clinical research
13
MEDLINE-indexed
journals for the
post-genomic era
Biomarkers in Medicine
MEDLINE-indexed
Impact Factor: 2.858
12 issues per year
7970 abstract views/month
Hop topics in all fields of
medical biomarker research
CNS Oncology
MEDLINE-indexed
6 issues per year
715 abstract views/month
Clinical and translational
research on, and management
of, tumors of the central
nervous system
Epigenomics
MEDLINE-indexed
Impact Factor: 5.215
8 issues per year
7435 abstract views/month
Focus on the description and
deciphering of genome-wide
interactions
Immunotherapy
MEDLINE-indexed
Impact Factor: 2.44
12 issues per year
9580 abstract views/month
Therapeutics that harness the
immune system to
combat disease
Journal of Comparative
Effectiveness Research
MEDLINE-indexed
Impact Factor: 1.119
6 issues per year
2250 abstract views/month
The only MEDLINE-indexed
journal focused specifically
on comparative effectiveness
research
Neurodegenerative Disease
Management
MEDLINE-indexed
6 issues per year
1395 abstract views/month
Managing neurodegenerative
disease in practice
14
ADDITIONAL JOURNALS
Breast Cancer Management
6 issues per year
Clinical Lipidology
Impact Factor: 0.855
6 issues per year
Colorectal Cancer
6 issues per year
Diabetes Management
6 issues per year
International Journal of
Clinical Rheumatology
CME articles
6 issues per year
International Journal of
Hematologic Oncology
6 issues per year
Interventional Cardiology
6 issues per year
Lung Cancer Management
6 issues per year
Personalized Medicine
Impact Factor: 1.132
6 issues per year
Pain Management
MEDLINE-indexed
6 issues per year
2200 abstract views/month
Latest research findings and
reviews in pain medicine
Women’s Health
MEDLINE-indexed
CME articles
6 issues per year
6895 abstract views/month
Editorials and reviews, drug
profiles and clinical trial reports
specific to women’s health
15
Future Science
Journals
16
11
Applied science and intellectual property
issues in R&D
Bioanalysis
MEDLINE-indexed
Impact Factor: 3.027
24 issues per year
16,900 abstract views/month
Scientific, technical and
regulatory developments in
bioanalysis
Associated eCommunity:
Bioanalysis Zone
Pharmaceutical
Patent Analyst
MEDLINE-indexed
6 issues per year
1900 abstract views/month
High-impact scientific reviews
of recent patents, discussed
within the context of other
R&D advances
Therapeutic Delivery
MEDLINE-indexed
12 issues per year
6870 abstract views/month
Comprehensive coverage of all
aspects of the evolving drug
delivery field
Future Medicinal Chemistry
MEDLINE-indexed
Impact Factor: 4.0
18 issues per year
12,550 abstract views/month
Design of small-molecule
bioactive agents and the
identification of
therapeutic targets
Clinical Investigation
12 issues per year
2220 abstract views/month
Forward-looking view of the
field for those involved in all
stages of clinical research
Pharmaceutical Bioprocessing
8 issues per year
1110 abstract views/month
Forum for scientists engaged
in research at all stages of the
production process upstream
to downstream
17
eBooks
18
Specifically designed to enhance
comprehension and aid learning
CLINICAL INSIGHTS SERIES
Currently comprising 15
titles, Clinical Insights is our
most popular eBook series.
Clinical Insights presents expert
guidance on best practice,
supported by concise reviews
of emerging research.
Topics include:
• Chronic Pain
• HIV Prevention
• Influenza Surveillance
• Irritable Bowel Syndrome
• Obesity and Childhood
• Parkinson’s Disease
• Tuberculosis Prevention
Our present collection includes
over 160 titles spanning
all aspects of discovery,
development and clinical care.
FSG eBooks are DRM-free and
are openURL compliant.
ADDITIONAL FEATURES
•Fully indexed and searchable
to chapter level
•Delivered from a single
platform, interconnected to
other FSG content
•Fully integrated into the
library catalogue
•Free MARC records
•COUNTER compliant
usage statistics
SUBJECT COLLECTIONS
Our subject collections afford
low-cost coverage of a broad
range of topics. Subjects
include:
•Oncology
•Cardiology
•Neurology
•Immunology
•Infection
•Pharmaceutical Science
& Technology
•Analytical Chemistry
•Environmental Science
19
eCommunities
20
Niche communities that facilitate
collaboration and innovation
Bioanalysis Zone
www.bioanalysis-zone.com
With over 7000 registered users,
Bioanalysis Zone is the market-
leading online resource for the
global bioanalytical community
Associated publication:
Bioanalysis
(MEDLINE-indexed, IF 3.027)
Oncology Central
www.oncology-central.com
Oncology Central offers easy
access to breaking news and
peer-reviewed articles in a
clinician-curated environment
Associated publication:
Future Oncology
(MEDLINE-indexed, IF 2.611)
plus 8 other journals and
31 eBooks
21
Our eCommunities are built
to meet the specific needs of
niche scientific and medical
communities. Enriched with
high-value expert insight and
integration with social media,
our websites enhance the value
of our publications
RegMedNet
www.regmednet.com
RegMedNet will provide a
unique and unparalleled
platform for the regenerative
medicine community to share
insights, discuss the latest
research, and help move the
field forward
Associated publication:
Regenerative Medicine
(MEDLINE-indexed, IF 3.5)
Dedicated in-house support for authors and
publication professionals
Publish with Future Science Group to benefit from:
•Fast-track publication as standard: as little as 12 weeks from
submission to publication
•Accelerated publication options: online publication within 6
weeks of article submission
•Indexing in MEDLINE and other major databases: providing
growing Impact Factors and discoverability
•Trusted, ethical publication standards: requirements of
CONSORT, COPE, GPP2 and ICMJE endorsed fully
•Excellent author experience and feedback: dedicated,
experienced editors providing personal communication and
follow-up from initial submission through to publication
•World-leading network of authors, reviewers and advisors:
ensuring the highest standards of publication
•Global distribution: all options available, including open access,
reprints, ePrints and online hosting
Future Science Group takes
a flexible and collaborative
approach to helping you
meet your communication
objectives, both before and
after publication. Publishing
Solutions is the in-house
medical education and
publishing support service
for Future Science Group
publications.
Our in-house editors are
on-hand to recommend the
most appropriate journal to
maximize readership and
return for your article.
Please contact
Joanne Walker at:
j.walker@future-science-group.com
if you would like further
information on these options.
22
PUBLISHING SOLUTIONS
Personalized and targeted campaigns that
focus on your potential customers
Other client
opportunities include:
•Webinars and seminars
•Sponsored audio and
video recordings
•Product and company listings
•Symposia, conference
reports, and special issues
•Article reprints
•Sponsored access
•Sponsored subscriptions
•Bespoke eBooks and
custom content
•Targeted advertising
placements
MARKETING AND COMMUNICATION SUPPORT
There are now so many opportunities to communicate with people it is
sometimes hard to know the most effective way to reach your particular
target audience. At Future Science Group, we offer our genuine insight
into scientific communities to help you make sure your campaign
reaches the right people in the right way.
Every project begins with an understanding of your goals. With our
broad portfolio of journals and client opportunities we then create
personalized and targeted campaigns that focus on your potential
customers. With our in-house editorial and design teams we can offer
you dedicated support to make sure the optimal message is delivered.
We want your campaign to be a success and know how important it is
to be able to define your ROI so we provide a detailed analytics report
for every project we undertake to help you justify your marketing spend
and plan your future campaigns.
Please contact
Dionne Murray at:
d.murray@future-science-group.com
if you would like further information.
23
Contact us
For more information about our
journals, eBooks or eCommunities email:
info@future-science-group.com
For more information about institutional trials:
trials@future-science-group.com
Future Science Group
Unitec House
2 Albert Place
London, N3 1QB
United Kingdom
+44 (0)20 8371 6090
info@future-science-group.com
www.future-science-group.com
@futuresciencegp
